Clusterin (CLU) is considered one of the most important roles for pathogenesis of AD by influencing the structure and neurotoxic effects of Aβ deposits6–8, and some of the variants at CLU can affect its expression level in brain9,10. This evidence concerns the gene CLU and Alzheimer disease.